Neurodevelopment disorders related to the GRIN2B gene: Case report
DOI:
https://doi.org/10.33448/rsd-v10i8.17566Keywords:
GRIN2B gene; Neurodevelopmental Disorders; Mutation; Nervous system.Abstract
Objective: To understand the main neurodevelopmental disorders related to alterations in the GRIN2B gene. Methodology: A descriptive and documentary case report was carried out. Data collection was carried out through specific tools such as interviews with a structured questionnaire, exams and forms that contained information on research identification; history of the disease under study; symptomatic interrogation; pathological family history; general physical examination and directed to organs and systems; diagnostic hypotheses; medical procedures already performed (exams and pharmacological and non-pharmacological treatment). Results: It was found that the patient in the case reported has Autosomal Dominant Intellectual Deficiency 6 (GRIN2B-Related Neurodevelopmental Disorder), based on their clinical characteristics and identification of the pathogenic variant in heterozygosity on chromosome 12 of the GRIN2B gene, excluding the possibility from other causes. Conclusion: The importance of GRIN2B in the development of the human brain is highlighted, allied to the understanding of the main neurodevelopmental disorders related to alterations in the GRIN2B gene, being of high relevance for the diagnosis and prognosis of these patients by contributing to the training of professionals capable of performing an early diagnosis, with knowledge of the clinical characteristics of the genetic alteration, immediate treatment measures, thus improving the quality of life and prognosis of these patients.
References
Bell, S., Maussion, G., Jefri, M., Peng, H., Theroux, JF, Silveira, H., & Ernst, C. (2018). A interrupção de GRIN2B prejudica a diferenciação em neurônios humanos. Relatórios de células-tronco, 11 (1), 183-196.
Burnashev, N., & Szepetowski, P. (2015). NMDA receptor subunit mutations in neurodevelopmental disorders. Current opinion in pharmacology, 20, 73–82.
Fedele, L., Newcombe, J., Topf, M., Gibb, A., Harvey, R. J., & Smart, T. G. (2018). Disease-associated missense mutations in GluN2B subunit alter NMDA receptor ligand binding and ion channel properties. Nature communications, 9(1), 1-15.
Geisheker, M. R., Heymann, G., Wang, T., Coe, B. P., Turner, T. N., Stessman, H. A., & Eichler, E. E. (2017). Pontos críticos de mutação missense identificam genes de distúrbios do neurodesenvolvimento e domínios funcionais. Nature neuroscience, 20 (8), 1043-1051.
Hu, C., Chen, W., Myers, SJ, Yuan, H., & Traynelis, S. F. (2016). Variantes de GRIN2B humano em distúrbios do neurodesenvolvimento. Journal of pharmacological Science, 132 (2), 115-121.
Lemke, J. R., Hendrickx, R., Geider, K., Laube, B., Schwake, M., Harvey, R. J., & Weckhuysen, S. (2014). Mutações GRIN2B na síndrome de West e deficiência intelectual com epilepsia focal. Annals of neurology, 75 (1), 147-154.
Li, D., Yuan, H., Ortiz-Gonzalez, X. R., Marsh, E. D., Tian, L., McCormick, E. M., & Falk, M. J. (2016). A mutação dominante de novo GRIN2D causa uma encefalopatia epiléptica grave tratável com bloqueadores dos canais do receptor NMDA. The American Journal of Human Genetics, 99 (4), 802-816.
McRae, J. F., Clayton, S., Fitzgerald, T. W., Kaplanis, J., Prigmore, E., Rajan, D., & Kumar, V. K. (2017). Prevalência e arquitetura de mutações de novo em transtornos do desenvolvimento. Nature, 542 (7642), 433-438.
Myers, S. J., Yuan, H., Kang, J. Q., Tan, F., Traynelis, S. F., & Low, C. M. (2019). Papéis distintos das variantes GRIN2A e GRIN2B em condições neurológicas. F1000Research, 8, F1000 Faculty Rev-1940.
Ogden, K. K., Chen, W., Swanger, S. A., McDaniel, M. J., Fan, L. Z., Hu, C., & Yuan, H. (2017). Mecanismo molecular de mutações associadas à doença na hélice pré-M1 dos receptores NMDA e potencial farmacologia de resgate. PLoS genetics, 13 (1), e1006536.
Paoletti, P., Bellone, C., & Zhou, Q. (2013). Diversidade de subunidades do receptor NMDA: impacto nas propriedades do receptor, plasticidade sináptica e doença. Nature Reviews Neuroscience, 14 (6), 383-400.
Pereira, A. S., Shitsuka, D. M., Parreira, F. B., & Shitsuka, R. (2018). Metodologia da pesquisa científica UFSM. https://repositorio.ufsm. br/bitstream/handle/1/15824/Lic_Computacao_MetodologiaPesquisa-Cientifica. pdf.
Platzer K, Lemke JR. Desordem do neurodesenvolvimento relacionada a GRIN2B. (2018). In: Adam MP, Ardinger HH, Pagon RA, et al., Editores. GeneReviews 1993-2021. https://www.ncbi.nlm.nih.gov/books/NBK501979/
Platzer, K., Yuan, H., Schütz, H., Winschel, A., Chen, W., Hu, C., & Lemke, J. R (2017). Encefalopatia GRIN2B: novos achados sobre fenótipo, agrupamento variante, consequências funcionais e aspectos do tratamento. Journal of medical genetics, 54 (7), 460-470.
Prodanov, C. C., & de Freitas, E. C. (2013). Metodologia do trabalho científico: métodos e técnicas da pesquisa e do trabalho acadêmico-2ª Edição. Editora Feevale.
Satterstrom, F K, Kosmicki, J., Wang, J., Breen, M., de Rubeis, S., An, J. Y, & Buxbaum, J. (2020). Estudo de sequenciamento de exoma em larga escala implica mudanças de desenvolvimento e funcionais na neurobiologia do autismo. Cell, 180 (3), 568-584.
Sestan, N., & State, MW (2018). Perdido na tradução: atravessando o caminho complexo da genômica à terapêutica no transtorno do espectro do autismo. Neuron, 100 (2), 406-423.
Sharawat, I., Yadav, J., & Saini, L. (2019). Nova mutação GRIN2B: uma causa rara de encefalopatia epiléptica grave. Neurology India, 67 (2), 562-563.
Soto, D., Olivella, M., Grau, C., Armstrong, J., Alcon, C., Gasull, X., & Altafaj, X. (2019). A suplementação dietética com L-serina está associada à melhora clínica da encefalopatia pediátrica relacionada à perda de função GRIN2B. Science signaling, 12 (586).
Taylor, D. L, Tiwari, A. K, Lieberman, J. A, Potkin, S. G, Meltzer, H. Y, Knight, J., & Kennedy, J. L (2016). Análise de associação genética do gene GRIN2B da subunidade do receptor de N-metil-d-aspartato e resposta clínica à clozapina. Human Psychopharmacology: Clinical and Experimental, 31 (2), 121-134.
Vieira, M. M., Jeong, J., & Roche, K. W. (2021). The role of NMDA receptor and neuroligin rare variants in synaptic dysfunction underlying neurodevelopmental disorders. Current opinion in neurobiology, 69, 93–104.
Volk, L., Chiu, S. L, Sharma, K., & Huganir, R. L (2015). Sinapses de glutamato em distúrbios cognitivos humanos. Revisão anual da neurociência, 38, 127-149.
Wells, G., Yuan, H., McDaniel, M. J, Kusumoto, H., Snyder, J. P, Liotta, D. C, & Traynelis, S. F (2018). A variante do receptor GluN2B-Glu413Gly NMDA decorrente de uma mutação GRIN2B de novo promove a desconexão do ligante e a abertura do domínio. Proteins, 86 (12), 1265–1276.
Wilfert, A .B, Sulovari, A., Turner, T. N, Coe, B P, & Eichler, E. E (2017). Mutações recorrentes de novo em distúrbios do neurodesenvolvimento: propriedades e implicações clínicas. Medicina do genoma, 9 (1), 1-16.
XiangWei, W., Jiang, Y., & Yuan, H. (2018). Mutações de novo e variantes raras que ocorrem em receptores NMDA. Opinião atual em fisiologia, 2, 27-35.
Yin, R. K. (2015). Estudo de Caso-: Planejamento e métodos. Bookman editora.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Damiana Gerleide Brito Valério; Raquel Bezerra de Sá de Sousa Nogueira; Maria Cecília de Pontes Jordão Gayoso; Tiago Bezerra de Sá de Sousa Nogueira; Alanna Michely Batista de Morais
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
